All Stories

  1. Using speed networking to connect medical students with research supervisors

    Article • Canadian Medical Education Journal, May 2026, The Association of Faculties of Medicine of Canada

    Dr Marc-Olivier Deguise

  2. Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

    Article • Journal of Visualized Experiments, October 2025, MyJove Corporation

    Dr Marc-Olivier Deguise

  3. Bullying experiences of youth with neuromuscular disorders and their well-being: A survey study

    Article • Journal of Neuromuscular Diseases, August 2025, SAGE Publications

    Dr Marc-Olivier Deguise

  4. The Role of Mesenchymal Stromal Cells in the Treatment of Bronchopulmonary Dysplasia: A Multi‐Prong Approach for a Heterogeneous Disease

    Article • Comprehensive Physiology, August 2025, Wiley

    Dr Marc-Olivier Deguise

  5. NIPPV vs CPAP: Lessons from meta-analyses

    Article • Seminars in Perinatology, March 2025, Elsevier

    Dr Marc-Olivier Deguise

  6. Cell-based therapies in preclinical models of necrotizing enterocolitis: a systematic review and meta-analysis

    Article • Stem Cells Translational Medicine, February 2025, Oxford University Press (OUP)

    Dr Marc-Olivier Deguise

  7. Liver SMN restoration rescues the Smn mouse model of spinal muscular atrophy

    Article • EBioMedicine, December 2024, Elsevier

    Dr Marc-Olivier Deguise, Dr Bernard L Schneider

  8. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation

    Article • Cochrane Database of Systematic Reviews, July 2023, Wiley

    Dr Marc-Olivier Deguise

  9. Early nasal intermittent positive pressure ventilation (NIPPV) versus early nasal continuous positive airway pressure (NCPAP) for preterm infants

    Article • Cochrane Database of Systematic Reviews, July 2023, Wiley

    Dr Marc-Olivier Deguise

  10. Congenital dyserythropoietic anemia type IV in the genetic era: A rare neonatal case report of rapid identification with a review of the literature

    Article • Pediatric Blood & Cancer, February 2023, Wiley

    Dr Marc-Olivier Deguise

  11. Congenital dyserythropoietic anemia type IV in the genetic era: A rare neonatal case report of rapid identification with a review of the literature

    Article • October 2022, Wiley

    Dr Marc-Olivier Deguise

  12. Suppression of the necroptotic cell death pathways improves survival in Smn2B/− mice

    Article • Frontiers in Cellular Neuroscience, August 2022, Frontiers

    Dr Marc-Olivier Deguise

  13. Central and peripheral delivered AAV9-SMN are both efficient but target different pathomechanisms in a mouse model of spinal muscular atrophy

    Article • Gene Therapy, April 2022, Springer Science + Business Media

    Dr Bernard L Schneider, Dr Marc-Olivier Deguise

  14. Survival motor neuron protein deficiency alters microglia reactivity

    Article • Glia, April 2022, Wiley

    Dr Marc-Olivier Deguise

  15. Resident Match During the COVID Pandemic: How Have Neurology Programs Adapted? – A Survey

    Article • Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, February 2022, Cambridge University Press

    Dr Marc-Olivier Deguise

  16. Central and peripheral delivery of AAV9-SMN target different pathomechanisms in a mouse model of spinal muscular atrophy

    Article • November 2021, Cold Spring Harbor Laboratory Press

    Dr Marc-Olivier Deguise

  17. Metabolic Dysfunction in Spinal Muscular Atrophy

    Article • International Journal of Molecular Sciences, May 2021, MDPI AG

    Dr Marc-Olivier Deguise

  18. SMN Depleted Mice Offer a Robust and Rapid Onset Model of Nonalcoholic Fatty Liver Disease

    Article • Cellular and Molecular Gastroenterology and Hepatology, January 2021, Elsevier

    Dr Marc-Olivier Deguise, Dr Bernard L Schneider

  19. Weakness is more prominent in males in a new mild mouse model of spinal muscular atrophy

    Article • EBioMedicine, May 2020, Elsevier

    Dr Marc-Olivier Deguise

  20. A mouse model for spinal muscular atrophy provides insights into non-alcoholic fatty liver disease pathogenesis

    Article • April 2020, Cold Spring Harbor Laboratory Press

    Dr Marc-Olivier Deguise

  21. Blood Flow to the Spleen is Altered in a Mouse Model of Spinal Muscular Atrophy

    Article • Journal of Neuromuscular Diseases, April 2020, IOS Press

    Dr Marc-Olivier Deguise, Dr Bernard L Schneider

  22. Low fat diets increase survival of a mouse model of spinal muscular atrophy

    Article • Annals of Clinical and Translational Neurology, October 2019, Wiley

    Dr Marc-Olivier Deguise

  23. Impaired kidney structure and function in spinal muscular atrophy

    Article • Neurology Genetics, August 2019, Wolters Kluwer Health

    Dr Marc-Olivier Deguise

  24. Abnormal fatty acid metabolism is a core component of spinal muscular atrophy

    Article • Annals of Clinical and Translational Neurology, July 2019, Wiley

    Dr Marc-Olivier Deguise

  25. P.068 Abnormal fatty acid metabolism is a feature of spinal muscular atrophy

    Article • Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, June 2019, Cambridge University Press

    Dr Marc-Olivier Deguise

  26. Into the unknown

    Article • January 2019, Elsevier

    Dr Marc-Olivier Deguise

  27. SMA CLINICAL DATA, OUTCOME MEASURES AND REGISTRIES

    Article • Neuromuscular Disorders, October 2018, Elsevier

    Dr Marc-Olivier Deguise

  28. Interventions Targeting Glucocorticoid-Krüppel-like Factor 15-Branched-Chain Amino Acid Signaling Improve Disease Phenotypes in Spinal Muscular Atrophy Mice

    Article • EBioMedicine, May 2018, Elsevier

    Dr Marc-Olivier Deguise

  29. Abnormal fatty acid metabolism is a feature of spinal muscular atrophy

    Article • Neuromuscular Disorders, October 2017, Elsevier

    Dr Marc-Olivier Deguise

  30. New insights into SMA pathogenesis: immune dysfunction and neuroinflammation

    Article • Annals of Clinical and Translational Neurology, May 2017, Wiley

    Dr Marc-Olivier Deguise

  31. The glucocorticoid-KLF15-BCAA pathway as a novel therapeutic target for spinal muscular atrophy

    Article • Neuromuscular Disorders, March 2017, Elsevier

    Dr Marc-Olivier Deguise

  32. The role of the TWEAK/Fn14 pathway in muscle pathology in SMA

    Article • Neuromuscular Disorders, March 2017, Elsevier

    Dr Marc-Olivier Deguise

  33. Immune dysregulation may contribute to disease pathogenesis in spinal muscular atrophy mice

    Article • Human Molecular Genetics, January 2017, Oxford University Press (OUP)

    Dr Marc-Olivier Deguise

  34. Oligodendrocyte development and CNS myelination are unaffected in a mouse model of severe spinal muscular atrophy

    Article • Human Molecular Genetics, January 2017, Oxford University Press (OUP)

    Dr Marc-Olivier Deguise

  35. Contributions of Different Cell Types to Spinal Muscular Atrophy Pathogenesis

    Article • January 2017, Elsevier

    Dr Marc-Olivier Deguise

  36. Differential induction of muscle atrophy pathways in two mouse models of spinal muscular atrophy

    Article • Scientific Reports, June 2016, Springer Science + Business Media

    Dr Marc-Olivier Deguise

  37. Acute Stroke Research: Being Part of a Game-Changer with Dr. Dar Dowlatshahi, Scientific Director of the Ottawa Stroke Program

    Article • University of Ottawa Journal of Medicine, November 2015, University of Ottawa Library

    Dr Marc-Olivier Deguise

  38. Defects in muscle maturation contribute to spinal muscular atrophy.

    Article • Human Molecular Genetics, April 2014, Oxford University Press (OUP)

    Dr Marc-Olivier Deguise